Top

Surgical Endoscopy

Published in:

01-05-2014

Elective antireflux surgery in the US: an analysis of national trends in utilization and inpatient outcomes from 2005 to 2010

Authors: Luke M. Funk, Aliyah Kanji, W. Scott Melvin, Kyle A. Perry

Published in: Surgical Endoscopy | Issue 5/2014

Abstract

Background

Previous research suggested that antireflux surgery reached its peak volume in the US more than a decade ago. Factors such as changes in population demographics and improvements in surgical outcomes may have reversed this decline. We sought to examine national trends in the management of antireflux surgery patients and identify patient and hospital characteristics associated with postoperative complications.

Methods

We analyzed data from the Nationwide Inpatient Sample to identify adults with gastroesophageal reflux disease or esophagitis who underwent elective antireflux surgery between 2005 and 2010. Patient and hospital characteristics were analyzed. A multivariate logistic regression model was used to identify characteristics associated with an increased risk of postoperative complications following laparoscopic antireflux surgery.

Results

The volume of elective antireflux surgery remained relatively stable between 2005 (n = 15,819) and 2010 (n = 18,780). The percentage of patients older than 64 years of age increased from 21.1 % in 2005 to 30.9 % in 2010 (p < 0.01), while the percentage with a Charlson score over 2 more than doubled (1.2–2.7 %; p < 0.01). Inpatient complication rates (6.3 vs. 6.6 %; p = 0.21) and mortality (0.08 vs. 0.21; p = 0.72) were unchanged. On multivariate analysis, patients older than 79 years were three times as likely to develop a complication (odds ratio [OR] 3.1; 95 % CI 2.1–4.5) as were patients with a Charlson score over 2 (OR 3.1; 95 % CI 2.2–4.3).

Conclusions

Today’s antireflux surgery patient population is a higher-risk cohort, but complication rates have remained stable and inpatient mortality has declined more than 50 % over the past decade. Given these findings, additional research is needed to understand why antireflux surgery is underutilized, with a decline of more than two-thirds since its peak in 1999.

Finlayson SR, Laycock WS, Birkmeyer JD (2003) National trends in utilization and outcomes of antireflux surgery. Surg Endosc 17:864–867PubMedCrossRef

Finks JF, Yongliang W, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701PubMedCrossRef

Wang YR, Dempsey DT, Richter JE (2001) Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1993–2006. Dis Esophagus 24:215–223CrossRef

Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 326:786–792PubMedCrossRef

Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F et al (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338PubMedCrossRef

Friedenberg FK, Hanlon A, Vanar V, Nehemia D, Mekapati J, Nelson DB et al (2010) Trends in gastroesophageal reflux disease as measured by the national ambulatory medical care survey. Dig Dis Sci 55:1911–1917PubMedCrossRef

Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953PubMedCrossRef

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M et al (2010) Iatrogenic gastric acid suppression and the risk of nosomoical Clostridium difficile infection. Arch Intern Med 170:784–790PubMedCrossRef

Semel ME, Lipsitz SR, Funk LM, Bader AM, Weiser TG, Gawande AA (2012) Rates and patterns of death after surgery in the United States, 1996 and 2006. Surgery 151:171–182PubMedCrossRef

10.

Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W et al (2011) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc 25:2547–2554PubMedCrossRef

11.

Mahon D, Rhodes M, Decadt B, Hindmarsh A, Lowndes R, Beckingham I et al (2005) Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 92:695–699PubMedCrossRef

12.

Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Malm A, Nordic GORD Study Group (2007) Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 94:198–203PubMedCrossRef

13.

Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, Guidelines Committee SAGES (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24:2647–2649PubMedCrossRef

14.

Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2010. Healthcare cost and utilization project. Rockville: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2010.jsp. Accessed 14 Jan 2013

15.

United States Census Bureau. Population estimates. National intercensal estimates (2000–2010). http://www.census.gov/popest/data/intercensal/national/nat2010.html. Accessed 8 Jan 2013

16.

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

17.

Rao JN, Scott AJ (1987) On simple adjustments to Chi square tests with survey data. Ann Stat 15:385–397CrossRef

18.

Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130PubMedCrossRef

19.

Ghaferi AA, Birkmeyer JD, Dimick JB (2009) Variation in hospital mortality associated with inpatient surgery. N Engl J Med 361:1368–1375PubMedCrossRef

20.

Niebisch S, Fleming FJ, Galey KM, Wilshire CL, Jones CE, Litle VR et al (2012) Perioperative risk of laparoscopic fundoplication: safer than previously reported—analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005–2009. J Am Coll Surg 215:61–68PubMedCrossRef

21.

Ingraham AM, Cohen ME, Bilimoria KY, Pritts TA, Ko CY, Esposito TJ (2010) Comparison of outcomes after laparoscopic versus open appendectomy for acute appendicitis at 222 ACS NSQIP hospitals. Surgery 148:625–635 discussion 635–637PubMedCrossRef

22.

Ingraham AM, Cohen ME, Ko CY, Hall BL (2010) A current profile and assessment of North American cholecystectomy: results from the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 211:176–186PubMedCrossRef

23.

Rotman SR, Bishop TF (2013) Proton pump inhibitor use in the U.S. ambulatory setting, 2002–2009. PLoS One 8(2):e56060PubMedCentralPubMedCrossRef

24.

Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM et al (2005) Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 3:543–552PubMedCrossRef

25.

Liu JY, Finlayson SR, Laycock WS, Rothstein RI, Trus TL, Pohl H et al (2003) Determining an appropriate threshold for referral to surgery for gastroesophageal reflux disease. Surgery 133:5–12PubMedCrossRef

26.

Chey WD, Inadomi JM, Booher AM, Sharma VK, Fendrick AM, Howden CW (2005) Primary-care physicians‘perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol 100:1237–1242PubMedCrossRef

27.

Bretagne JF, Rey JF, Caekaert A, Barthelemy P (2005) Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study. Dig Liver Dis 37:566–570PubMedCrossRef

28.

Grant AM, Boachie C, Cotton SC, Faria R, Bojke L, Epstein DM, REFLUX trial group (2013) Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicenter randomized trial (the REFLUX trial). Health Technol Assess 17:1–166PubMed

Title: Elective antireflux surgery in the US: an analysis of national trends in utilization and inpatient outcomes from 2005 to 2010
Authors: Luke M. Funk
Aliyah Kanji
W. Scott Melvin
Kyle A. Perry
Publication date: 01-05-2014
Publisher: Springer US
Published in: Surgical Endoscopy / Issue 5/2014
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-013-3380-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Elective antireflux surgery in the US: an analysis of national trends in utilization and inpatient outcomes from 2005 to 2010

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2014

Differences in colonoscopy technique impact quality

The composition of surgical teams in the operating room and its impact on surgical team performance in China

A modular magnetic anastomotic device for minimally invasive digestive anastomosis: proof of concept and preliminary data in the pig model

Surgical technique of robotic D3 lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery and autonomic nerves for the treatment of distal rectal cancer

Relevant risk factors and prognostic impact of positive resection margins after endoscopic submucosal dissection of superficial esophageal squamous cell neoplasia

Premedication with erythromycin improves endoscopic visualization of the gastric mucosa in patients with subtotal gastrectomy: a prospective, randomized, controlled trial